SCHEMBL18796284

SCHEMBL18796284

COc1cccc(Oc2nc3ccc(F)c(F)c3nc2C)c1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 6/20 0.36
▸ MAPT P10636 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ G6PD P11413 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ CASP6 P55212 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ AMY1A P0DUB6 4/20 0.33
▸ ATP4A P20648 1/20 0.33
▸ ATP4B P51164 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18795926 0.90 ALDH1A1 (0.34) ALDH1A1
SCHEMBL18795948 0.89 LYN (0.33) NQO2MAPTPOLBRAB9ANPC1
SCHEMBL18796283 0.87 MPL (0.32) PDE2APDE10A
SCHEMBL18796275 0.86 NQO2 (0.32) NQO2MAPTMEN1KMT2AKDM4E
SCHEMBL18796299 0.83 ALDH1A1 (0.34) LMNAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL18796223 0.83 LCK (0.40) NQO2MAPTPOLBRAB9ANPC1
SCHEMBL18796310 0.82 ALDH1A1 (0.39) NQO2MAPTPOLBRAB9ANPC1
SCHEMBL20551276 0.80 MAP4K4 (0.34) ALDH1A1PDE2APDE10A
SCHEMBL18796202 0.79 LYN (0.37) NQO2MAPTPKMAMY1A
SCHEMBL18796315 0.79 AMY1A (0.35) NQO2AMY1APDE2APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 — — US disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 — — US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 — — EP disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT NQO2 536/4885MAPT 3403/4885POLB 2980/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT NQO2 536/4885MAPT 3403/4885POLB 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback